• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五味子丙素增强I型干扰素反应激活,通过抗肿瘤免疫减少肿瘤生长并使化疗敏感。

Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity.

作者信息

Yang Huijie, Zhan Xiaoyan, Zhao Jia, Shi Wei, Liu Tingting, Wei Ziying, Li Hui, Hou Xiaorong, Mu Wenqing, Chen Yuanyuan, Zheng Congyang, Wang Zhongxia, Wei Shengli, Xiao Xiaohe, Bai Zhaofang

机构信息

School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

China Military Institute of Chinese Materia, The Fifth Medical Center of PLA General Hospital, Beijing, China.

出版信息

Front Pharmacol. 2024 Aug 7;15:1369563. doi: 10.3389/fphar.2024.1369563. eCollection 2024.

DOI:10.3389/fphar.2024.1369563
PMID:39170700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11337024/
Abstract

With the advancing comprehension of immunology, an increasing number of immunotherapies are being explored and implemented in the field of cancer treatment. The cGAS-STING pathway, a crucial element of the innate immune response, has been identified as pivotal in cancer immunotherapy. We evaluated the antitumor effects of lignan component Schisandrin C (SC) in 4T1 and MC38 tumor-bearing mice, and studied the enhancing effects of SC on the cGAS-STING pathway and antitumor immunity through RNA sequencing, qRT-PCR, and flow cytometry. Our findings revealed that SC significantly inhibited tumor growth in models of both breast and colon cancer. This suppression of tumor growth was attributed to the activation of type I IFN response and the augmented presence of T cells and NK cells within the tumor. Additionally, SC markedly promoted the cGAS-STING pathway activation induced by cisplatin. In comparison to cisplatin monotherapy, the combined treatment of SC and cisplatin exhibited a greater inhibitory effect on tumor growth. The amplified chemotherapeutic efficacy was associated with an enhanced type I IFN response and strengthened antitumor immunity. SC was shown to reduce tumor growth and increase chemotherapy sensitivity by enhancing the type I IFN response activation and boosting antitumor immunity, which enriched the research into the antitumor immunity of and laid a theoretical basis for its application in combating breast and colon cancer.

摘要

随着对免疫学理解的不断深入,越来越多的免疫疗法在癌症治疗领域得到探索和应用。环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白(cGAS-STING)通路作为天然免疫反应的关键要素,已被确定在癌症免疫治疗中起关键作用。我们评估了木脂素成分五味子丙素(SC)对4T1和MC38荷瘤小鼠的抗肿瘤作用,并通过RNA测序、qRT-PCR和流式细胞术研究了SC对cGAS-STING通路及抗肿瘤免疫的增强作用。我们的研究结果显示,SC在乳腺癌和结肠癌模型中均显著抑制肿瘤生长。这种对肿瘤生长的抑制归因于I型干扰素反应的激活以及肿瘤内T细胞和自然杀伤(NK)细胞数量的增加。此外,SC显著促进了顺铂诱导的cGAS-STING通路激活。与顺铂单药治疗相比,SC与顺铂联合治疗对肿瘤生长的抑制作用更强。化疗疗效的增强与I型干扰素反应的增强和抗肿瘤免疫力的增强有关。研究表明,SC通过增强I型干扰素反应激活和增强抗肿瘤免疫力来减少肿瘤生长并提高化疗敏感性,这丰富了对其抗肿瘤免疫的研究,并为其在对抗乳腺癌和结肠癌中的应用奠定了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/f2faaf9e7d74/fphar-15-1369563-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/63c8abbf5527/fphar-15-1369563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/93a811d56be9/fphar-15-1369563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/256ddd540f29/fphar-15-1369563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/68a60fad6f71/fphar-15-1369563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/91876a75275b/fphar-15-1369563-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/e07c0c8d6280/fphar-15-1369563-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/f2faaf9e7d74/fphar-15-1369563-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/63c8abbf5527/fphar-15-1369563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/93a811d56be9/fphar-15-1369563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/256ddd540f29/fphar-15-1369563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/68a60fad6f71/fphar-15-1369563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/91876a75275b/fphar-15-1369563-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/e07c0c8d6280/fphar-15-1369563-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af35/11337024/f2faaf9e7d74/fphar-15-1369563-g007.jpg

相似文献

1
Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity.五味子丙素增强I型干扰素反应激活,通过抗肿瘤免疫减少肿瘤生长并使化疗敏感。
Front Pharmacol. 2024 Aug 7;15:1369563. doi: 10.3389/fphar.2024.1369563. eCollection 2024.
2
Schisandrin C enhances cGAS-STING pathway activation and inhibits HBV replication.五味子丙素增强cGAS-STING通路激活并抑制乙肝病毒复制。
J Ethnopharmacol. 2023 Jul 15;311:116427. doi: 10.1016/j.jep.2023.116427. Epub 2023 Mar 30.
3
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.锰通过 cGAS-STING 对抗肿瘤免疫反应至关重要,并提高了临床免疫疗法的疗效。
Cell Res. 2020 Nov;30(11):966-979. doi: 10.1038/s41422-020-00395-4. Epub 2020 Aug 24.
4
Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.肿瘤内源性 BANF1 的抑制通过 cGAS-STING 激活抗肿瘤免疫反应,并增强 PD-1 阻断的疗效。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-007035.
5
Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice.碳离子照射通过诱导前列腺癌荷瘤小鼠的 cGAS-STING 激活和免疫反应发挥抗肿瘤活性。
Cancer Med. 2024 Jan;13(2):e6950. doi: 10.1002/cam4.6950.
6
NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling.NR1D1 通过激活 cGAS-STING 信号促进乳腺癌中的抗肿瘤免疫反应。
Cancer Res. 2023 Sep 15;83(18):3045-3058. doi: 10.1158/0008-5472.CAN-23-0329.
7
Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.涉及 STING 通路激活的癌症免疫治疗策略:机制和激动剂。
Biochem Pharmacol. 2023 Jul;213:115596. doi: 10.1016/j.bcp.2023.115596. Epub 2023 May 16.
8
Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.放射治疗通过cGAS-STING激活诱导的PD-L1上调促进肝细胞癌免疫逃逸。
Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1243-1255. doi: 10.1016/j.ijrobp.2021.12.162. Epub 2022 Jan 2.
9
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.高压氧促进依托泊苷诱导的 cGAS-STING 激活,增强 PD-1 抗体在 HCC 中的抗肿瘤疗效。
J Immunother Cancer. 2022 Aug;10(8). doi: 10.1136/jitc-2021-004006.
10
The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges.cGAS-STING在抗肿瘤免疫中的多面性:前景与挑战
Med Rev (2021). 2024 Apr 15;4(3):173-191. doi: 10.1515/mr-2023-0061. eCollection 2024 Jun.

引用本文的文献

1
Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies.解析乳腺癌肿瘤微环境:影响自然杀伤细胞功能的关键因素及治疗策略
Int J Biol Sci. 2025 Mar 24;21(6):2606-2628. doi: 10.7150/ijbs.108803. eCollection 2025.
2
Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics.调控环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白信号轴:推进骨肉瘤治疗的创新策略
Front Immunol. 2025 Feb 7;16:1539396. doi: 10.3389/fimmu.2025.1539396. eCollection 2025.

本文引用的文献

1
Cisplatin-based combination therapy for cancer.基于顺铂的癌症联合治疗
J Cancer Res Ther. 2023 Apr-Jun;19(3):530-536. doi: 10.4103/jcrt.jcrt_792_22.
2
Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.涉及 STING 通路激活的癌症免疫治疗策略:机制和激动剂。
Biochem Pharmacol. 2023 Jul;213:115596. doi: 10.1016/j.bcp.2023.115596. Epub 2023 May 16.
3
Schisandrin C enhances cGAS-STING pathway activation and inhibits HBV replication.五味子丙素增强cGAS-STING通路激活并抑制乙肝病毒复制。
J Ethnopharmacol. 2023 Jul 15;311:116427. doi: 10.1016/j.jep.2023.116427. Epub 2023 Mar 30.
4
Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity.通过增强抗肿瘤免疫力,对cGAS激活进行药理学增强可使化疗更敏感。
Cell Rep. 2023 Mar 28;42(3):112275. doi: 10.1016/j.celrep.2023.112275. Epub 2023 Mar 20.
5
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy.STING 激动剂的发展及其作为癌症免疫疗法的新成果。
Curr Oncol Rep. 2023 Mar;25(3):189-199. doi: 10.1007/s11912-023-01361-0. Epub 2023 Jan 27.
6
Cisplatin in cancer treatment.顺铂在癌症治疗中的应用。
Biochem Pharmacol. 2022 Dec;206:115323. doi: 10.1016/j.bcp.2022.115323. Epub 2022 Nov 8.
7
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.顺铂和吉西他滨对 K-ras 驱动型癌症的 PD-1 抗体免疫疗法有相反的影响。
J Adv Res. 2022 Sep;40:109-124. doi: 10.1016/j.jare.2021.12.005. Epub 2021 Dec 21.
8
cGAS and cancer therapy: a double-edged sword.cGAS 与癌症治疗:一把双刃剑。
Acta Pharmacol Sin. 2022 Sep;43(9):2202-2211. doi: 10.1038/s41401-021-00839-6. Epub 2022 Jan 18.
9
Emerging immunological strategies: recent advances and future directions.新兴免疫策略:最新进展与未来方向。
Front Med. 2021 Dec;15(6):805-828. doi: 10.1007/s11684-021-0886-x. Epub 2021 Dec 6.
10
Curdione and Schisandrin C Synergistically Reverse Hepatic Fibrosis via Modulating the TGF-β Pathway and Inhibiting Oxidative Stress.莪术二酮与五味子丙素通过调节转化生长因子-β信号通路及抑制氧化应激协同逆转肝纤维化
Front Cell Dev Biol. 2021 Nov 10;9:763864. doi: 10.3389/fcell.2021.763864. eCollection 2021.